Glenmark Pharmaceuticals Share Price
₹1,541.65 +0.85 (0.06%)
22 Dec, 2024 21:37
Start SIP in GLENMARK
Start SIPPerformance
- Low
- ₹1,530
- High
- ₹1,561
- 52 Week Low
- ₹771
- 52 Week High
- ₹1,831
- Open Price₹1,530
- Previous Close₹1,541
- Volume644,522
Investment Returns
- Over 1 Month + 5.13%
- Over 3 Month -5.81%
- Over 6 Month + 25.28%
- Over 1 Year + 87.18%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -49.7
- PEG Ratio
- 0.1
- Market Cap Cr
- 43,504
- P/B Ratio
- 5.5
- Average True Range
- 46.78
- EPS
- 0
- Dividend Yield
- 0.2
- MACD Signal
- -22.98
- RSI
- 48.06
- MFI
- 42.47
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,541.65
+
0.85
(0.06%)
- Bullish Moving Average 11
- Bearish Moving Average 5
- 20 Day
- ₹1,541.10
- 50 Day
- ₹1,575.85
- 100 Day
- ₹1,546.03
- 200 Day
- ₹1,397.32
Resistance and Support
1544.13
- R3 1,588.87
- R2 1,574.78
- R1 1,558.22
- S1 1,527.57
- S2 1,513.48
- S3 1,496.92
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results | |
2024-05-24 | Audited Results & Final Dividend | |
2024-02-14 | Quarterly Results | |
2023-11-10 | Quarterly Results |
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,541 As on 22 December, 2024 | 21:23
The Market Cap of Glenmark Pharmaceuticals is ₹43503.5 Cr As on 22 December, 2024 | 21:23
The P/E ratio of Glenmark Pharmaceuticals is -49.7 As on 22 December, 2024 | 21:23
The PB ratio of Glenmark Pharmaceuticals is 5.5 As on 22 December, 2024 | 21:23
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.